INTRODUCTION
Diabetes mellitus (DM) is a common chronic disease worldwide, and the global health expenditure on DM is expected be at least 376 billion US dollars in 2010 and 490 billion US dollars in 2030 1 . Especially among Asian countries, the prevalence of DM has rapidly increased in recent decades with economic development accompanied by changes in food supply and dietary patterns, technology transfer, and cultural admixtures 2 .
In diabetic patients, the proportion of ischemic heart disease (IHD) is two-to fourfold higher 3 , the risk of stroke is approximately twofold greater 4 and the risk of peripheral arterial disease (PAD) is approximately fourfold greater 5 than in nondiabetic patients. In Japan, DM was reported as a risk factor for cardiovascular disease and coronary heart disease 6 , and DM is related to coronary heart disease among women and ischemic stroke among both sexes 7 . In addition, large nationwide cohort studies in Japan have suggested that DM and elevated glucose levels are associated with incident coronary heart disease 8 and ischemic stroke 9 in the general Japanese population.
In Japan, the National Diabetic Patients Survey reported that approximately 8.9 million people were strongly suspected of having DM 10 . Nevertheless, according to the National Health and Nutrition Survey carried out in 2009, just 2.37 million people received treatment for DM 11 . The Japanese government developed a set of indicators for health promotion for the period of 2001-2010, which is called "Healthy Japan 21" in financial year 2000. The midcourse review of these indicators reported that the proportion of adherence to treatment for DM and health guidance after health examinations slightly increased, but did not reach the targets 12 . Subsequently, the number of patients with diabetic complications had increased beyond the target 13 . However, there is no evidence of the effect of regular visits to physicians on in-hospital mortality of diabetic patients or the number of diabetic complications in Japan. Therefore, the objective of the present study was to evaluate the effect of irregular visits on diabetic macrovascular complications and inhospital mortality among diabetic patients.
MATERIALS AND METHODS

Data Source
We obtained data of diabetic patients who were newly hospitalized to the general ward between April 2010 and September 2010 from fee-for-service claims data of the Fukuoka National Health Insurance Organization. We combined them with medical claims data of outpatient visits between April 2009 and March 2010. We assessed only the first hospitalizations among patients who had experienced several hospitalizations, after excluding patients who had received hemodialysis or peritoneal dialysis. From a previous study using Japanese medical claims data of fee-for-service 14 , we identified diabetic patients by the diagnostic code of DM (International Classification of Diseases 10th revision [ICD-10] codes: E10-14) that they received when they were hospitalized.
Definition of Variables
Study variables included hospitalization for diabetic macrovascular complications, outcomes at discharge, age, sex, comorbidities and the use of insulin or oral hypoglycemic agents. Because Japanese medical claims data of the fee-for-service system often contain information on multiple diseases, diagnostic examinations and therapies, we converted primary diagnostic codes into sixdigit codes of the Diagnosis Procedure Combination/Per-Diem Payment System (DPC/PDPS), which is a Japanese prospective payment system 15 . Then, we combined the six-digit diagnostic codes (base DPC), those of surgical procedures, adjuvant therapies and other diagnostic codes as comorbidities/complications, into 14-digit DPC codes. Finally, we estimated the most resourceintensive diseases by hospitalization costs, which were calculated based on the reimbursement rule of the DPC/PDPS, and defined these diseases as the primary disease. We also defined hospitalization for diabetic macrovascular complications, including IHD, stroke and PAD, as shown in Table 1 .
Regular visits were defined as physician visits for DM at least every 3 months between April 2009 and March 2010, whereas other visits or no visits were defined as irregular visits. In other words, we counted months of physician visits by every quarter of the year, and defined physician visits throughout every quarter as regular visits. This timing was chosen because the expiry time of prescriptions is 3 months in the Japanese system of health insurance. Age was categorized into three groups: 64 years or younger, 65-74 years and 75 years or older. Medication for DM during hospitalization was categorized into four groups: no medication, oral hypoglycemic agents, insulin, and oral hypoglycemic agents and insulin. 16, 17 . The CCI was categorized into three categories: 0, 1 or 2, and 3 or higher 18 .
Statistical Analysis
Patient characteristics were constructed using frequencies and proportions for categorical variables, and using median and interquartile range for a continuous variable. Categorical variables were compared between the regular visit and irregular visit groups by Pearson's v 2 -tests, and the continuous variable was compared between the two groups by the Mann-Whitney test.
Propensity score matching was carried out to formulate a balanced 1:1 matched study, and to compare risks of hospitalization for diabetic macrovascular complications and in-hospital mortality between the regular visit and irregular visit groups. According to previous studies on variable selection of propensity score matching 19, 20 , propensity scores were calculated by a logistic regression model to identify the relationships between irregular visits and sex, age, hypertension, hyperlipidemia, other comorbidities indicated in the CCI, and dummy variables for 62 residential municipalities in Fukuoka Prefecture (i.e., 61 variables). The Hosmer-Lemeshow test and the C statistic were used as an indicator of how well the logistic regression model fitted the data. Using the SPSS macro for propensity score matching 21 , each patient of the irregular visit group was matched with a unique control of the regular visit group within a caliper width of 0.02 22 . Finally, we assigned 5,940 patients to each group, and the C statistic was 0.620. The Hosmer-Lemeshow test did not reject the null hypothesis (P = 0.227).
Multiple logistic regression analyses were used to estimate adjusted odds ratios (AORs) and 95% confidence intervals (95% CIs) for irregular visits. For the first model, we set hospitalization for diabetic macrovascular complications as the dependent variable, and age, sex, hypertension, hyperlipidemia, medication for DM, and irregular visits as independent variables. For the second model, we set in-hospital mortality as the dependent variable, and independent variables included those in the first model, as well as the CCI. Statistical analyses were carried out using PASW version 18.0 (SPSS Inc., Chicago, IL, USA), and Pvalues <0.05 were regarded as statistically significant.
RESULTS
Descriptive Statistics
We identified 4,015 patients in the irregular visit group and 4,121 patients in the regular visit group. Patient characteristics are shown in Table 2 . The proportion of those aged 75 years or older in the regular visit group was significantly higher than that in the irregular visit group. The median number of months of physician visits in the regular visit group was 11 months (interquartile range [IQR] 3), whereas that in the regular visit group was 2 months (IQR 5). The proportion of patients who received medications for DM in the regular visit group was significantly higher than that in the irregular visit group. The proportion of patients who had congestive heart failure in the regular visit group was significantly less than that in the irregular visit group, and the proportion of those who had pulmonary disease, cancer, or rheumatological disease was significantly higher than that in the irregular visit group. The proportion of patients who had hypertension or hyperlipidemia in the regular visit group was significantly higher than that in the irregular visit group. The proportion of patients hospitalized for AMI, IHDs except AMI, all IHDs, hemorrhagic stroke or all strokes in the regular visit group was significantly less than that in the irregular visit group. The mortality rate in the regular visit group was significantly less than that in the irregular visit group.
After propensity score matching, the proportion of patients who had congestive heart failure in the regular visit group was significantly less than that in the irregular visit group, and the proportion of those who had pulmonary disease or cancer was significantly higher than that in the irregular visit group (Table 3) . Table 4 shows comparisons of outcomes by physician visits after propensity score matching, and AORs and 95% CIs estimated by multiple logistic regression models. The irregular visit group had a significantly higher AMI (AOR 3.52; 95% CI 1.79-6.96), other IHDs except AMI (AOR 1.25; 95% CI 1.02-1.54), all IHDs (AOR 1.37; 95% CI 1.12-1.66), all strokes (AOR 1.29; 95% CI 1.04-1.60) and risk of hospitalization for diabetic macrovascular complications (AOR 1.28; 95% CI 1.10-1.48) than did the regular visit group.
Multivariate Analyses
DISCUSSION
We showed that there was a significant difference in the risk of hospitalization for IHD and stroke between the regular visit and irregular visit groups. The risk of hospitalization for AMI in the irregular visit group was higher than that in the regular visit group. The present study results suggest that regular visits might reduce hospitalization for diabetic macrovascular complications.
It is apparent that the regular visit group had higher adherence to treatments than did the irregular visit group. Several previous studies reported that lower adherence to medication for DM is associated with DM-related hospitalization 23, 24 . Patients who had not obtained at least 80% of their oral antihyperglycemic medication were reported to have a 2.53-fold higher risk of subsequent hospitalization among patients with type 2 diabetes To evaluate the risks of irregular visits more precisely, we separately estimated the rates and risks of hospitalization for stroke, IHD and PAD. We found that the risk of hospitaliza- tion for IHD was higher than that of hospitalization for stroke. A prospective cohort study in Japan reported that the incidence rate of IHD (9.68 per 1,000 person-years) was higher than that of cerebrovascular attack (6.78 per 1,000 person-years) among elderly type 2 DM patients 25 .
The present results are consistent with the results of that previous study.
The present study results suggested that it would be effective for insurers to motivate beneficiaries with DM to have regular visits. Insurers, especially health insurance societies, promote lifestyle modifications aimed at enhancing health and the promotion of primary prevention 26 . In addition to those health activities, the Japanese government has implemented "specific health checkup and health guidance" in financial year 2008 to reduce the number of persons at high risk of lifestyle-related diseases, including DM. Because insurers can discover the insured at high risk of lifestyle-related diseases or those complications from specific health checkup data and incorporate that data to claims data, it is expected that insurers will develop a disease management program by using these data. To develop a disease management program, further experimental studies are necessary to evaluate the effect of interventions for making regular visits and economic effects.
There were some limitations of the present study. First, we only investigated beneficiaries of the Fukuoka National Health Insurance Organization. Second, we could not investigate clinical information, such as family history, body mass index and other laboratory values (e.g., hemoglobin A1c). However, the present study included patients who did not have outpatient visits, although most previous studies did not include these patients.
In conclusion, the present study shows that the irregular visit group had significantly higher risks of hospitalization for IHD and stroke among diabetic patients. Strategies of insurers that motivate those beneficiaries with DM to make regular visits would be effective for reducing the risk of hospitalization for IHD and stroke.
